BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30692637)

  • 1. VPAC1 couples with TRPV4 channel to promote calcium-dependent gastric cancer progression via a novel autocrine mechanism.
    Tang B; Wu J; Zhu MX; Sun X; Liu J; Xie R; Dong TX; Xiao Y; Carethers JM; Yang S; Dong H
    Oncogene; 2019 May; 38(20):3946-3961. PubMed ID: 30692637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine.
    Jayawardena D; Guzman G; Gill RK; Alrefai WA; Onyuksel H; Dudeja PK
    Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G16-G25. PubMed ID: 28385693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium Promotes Human Gastric Cancer via a Novel Coupling of Calcium-Sensing Receptor and TRPV4 Channel.
    Xie R; Xu J; Xiao Y; Wu J; Wan H; Tang B; Liu J; Fan Y; Wang S; Wu Y; Dong TX; Zhu MX; Carethers JM; Dong H; Yang S
    Cancer Res; 2017 Dec; 77(23):6499-6512. PubMed ID: 28951460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.
    Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H
    Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPAC1 receptors regulate intestinal secretion and muscle contractility by activating cholinergic neurons in guinea pig jejunum.
    Fung C; Unterweger P; Parry LJ; Bornstein JC; Foong JP
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G748-58. PubMed ID: 24578344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M; Huang MC; Goetzl EJ
    Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation.
    Nam C; Case AJ; Hostager BS; O'Dorisio MS
    J Mol Neurosci; 2009 Feb; 37(2):160-7. PubMed ID: 18663606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
    Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J
    Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.
    Sághy É; Payrits M; Helyes Z; Reglődi D; Bánki E; Tóth G; Couvineau A; Szőke É
    Neuroscience; 2015 Nov; 308():144-56. PubMed ID: 26321242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide (VIP) stimulates cortisol secretion from the H295 human adrenocortical tumour cell line via VPAC1 receptors.
    Nicol MR; Cobb VJ; Williams BC; Morley SD; Walker SW; Mason JI
    J Mol Endocrinol; 2004 Jun; 32(3):869-77. PubMed ID: 15171718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of a specific peptide binding to VPAC1 receptor from a phage display peptide library.
    Tang B; Li Z; Huang D; Zheng L; Li Q
    PLoS One; 2013; 8(1):e54264. PubMed ID: 23365656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial expression of vasoactive intestinal peptide in ulcerative colitis: down-regulation in markedly inflamed colon.
    Jönsson M; Norrgård O; Forsgren S
    Dig Dis Sci; 2012 Feb; 57(2):303-10. PubMed ID: 22143367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors.
    Cunha-Reis D; Aidil-Carvalho Mde F; Ribeiro JA
    Hippocampus; 2014 Nov; 24(11):1353-63. PubMed ID: 24935659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1.
    Balster DA; O'Dorisio MS; Albers AR; Park SK; Qualman SJ
    Regul Pept; 2002 Nov; 109(1-3):155-65. PubMed ID: 12409228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
    Cunha-Reis D; Ribeiro JA; Sebastião AM
    Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasoactive intestinal peptide on gastric adenocarcinoma.
    Li GH; Qian W; Song GQ; Hou XH
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1328-35. PubMed ID: 17559364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
    Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of PEGylated VPAC1-selective antagonists that inhibit proliferation of a lung cancer cell line.
    Pan CQ; Hamren S; Roczniak S; Tom I; DeRome M
    Peptides; 2008 Mar; 29(3):479-86. PubMed ID: 17942192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. Analysis of potential prognostic relevance.
    Fernández-Martínez AB; Carmena MJ; Arenas MI; Bajo AM; Prieto JC; Sánchez-Chapado M
    Histol Histopathol; 2012 Aug; 27(8):1093-101. PubMed ID: 22763881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression of vasoactive intestinal peptide receptors in human lung cancer.
    Szilasi M; Buglyo A; Treszl A; Kiss L; Schally AV; Halmos G
    Int J Oncol; 2011 Oct; 39(4):1019-24. PubMed ID: 21769421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.